Most pens only go as low as 0.25 mg increments or have fixed dose options
C., Hayes, M., Houmard, J
Acta Neuropsychiatr 34:318329 Altamimi TR, Thomas PD, Darwesh AM, Fillmore N, Mahmoud MU, Zhang L, Gupta A, Al Batran R, Seubert JM, Lopaschuk GD (2018) Cytosolic carnitine acetyltransferase as a source of cytosolic acetyl-COA: a possible mechanism for regulation of cardiac energy metabolism
Nardin RA, Johns DR: Mitochondrial dysfunction and neuromuscular disease
[6] Treating cagrilintide and tirzepatide as the same kind of drug misreads the biology: they touch appetite from different directions, and neither pathway makes one a substitute for the other
Aside from obesity and type 2 diabetes, the conditions that specialists use GLP-1RAs to treat align closely with their areas of practice